TY - JOUR T1 - Management of COVID-19 in special populations with kidney disease JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med DO - 10.3949/ccjm.87a.ccc067 AU - Yeshwanter Radhakrishnan AU - Mohamed Hassanein AU - Brian Stephany Y1 - 2020/12/03 UR - http://www.ccjm.org/content/early/2020/12/01/ccjm.87a.ccc067.abstract N2 - Although the literature is limited, early evidence suggests that patients with chronic kidney disease, end-stage kidney disease, and kidney transplant recipients are at increased risk for severe COVID-19 disease and death. Hence, management should focus on both infection prevention and treatment. There is currently a lack of evidence and guideline recommendations on optimal management of immunosuppression in kidney transplant recipients with COVID-19 infection. This article focuses on the prevention and management of COVID-19 in patients with chronic kidney disease, patients with end-stage kidney disease on home hemodialysis and peritoneal dialysis, and kidney transplant recipients. ER -